Europe News
Most Popular Europe Story
UCB CEO plots strategy following Cimzia approval
Fresh off the FDA's approval of Cimzia for Crohn's disease, UCB chief executive Roch Doliveux forecast a swift regulatory success in Europe. Cimzia is one of the most closely watched late-stage... Read more...
Latest Headlines
- January 14, 2009
- October 7, 2008
- May 13, 2008
- April 24, 2008
- April 15, 2008
- April 7, 2008
- February 15, 2008
- February 4, 2008
- January 17, 2008
- December 20, 2007
- November 27, 2007
- November 19, 2007
- November 6, 2007
- October 26, 2007
- October 25, 2007
- October 8, 2007
- September 17, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
